Literature DB >> 10997350

Assessment of regional left ventricular function during exercise test with pulsed tissue Doppler imaging.

A Dagianti1, A Vitarelli, Y Conde, M Penco, F Fedele, A Dagianti1.   

Abstract

To investigate whether mitral annular velocity, measured by tissue Doppler imaging (TDI), is able to get a feasible quantitative evaluation of global and regional left-ventricular function during exercise test, 29 patients with previous uncomplicated myocardial infarction were studied by exercise echocardiography. All patients underwent coronary arteriography within 10 days of stress echocardiography. All of them were in sinus rhythm and had no right or left bundle branch block or significant mitral regurgitation as observed by left ventriculography. A total of 12 patients had anteroseptal and/or posteroseptal wall asynergies and left anterior descending involvement; 9 patients had lateral and/or posteroinferior asynergies and left circumflex coronary artery involvement; 8 patients had inferior and posteroseptal wall asynergies and right coronary artery involvement. Twelve subjects of same age and sex with normal cardiovascular findings were selected as a control group. TDI sample volumes were set on the mitral annuli corresponding to anteroseptal, posterior, posteroseptal, lateral, anterior, and inferior wall in 4-chamber, 2-chamber, and long-axis views. There was a significant correlation between the left-ventricular ejection fraction (0.41 +/- 0.8) and the means of the systolic (S) values (6.1 +/- 0.9 cm/sec, r = 0.83, p < 0.01). The mean S at the sites corresponding to the infarct regions (5.5 +/- 0.4 cm/sec) was significantly lower than the control group (11 +/- 0.8 cm/sec, p < 0.001). After stress, in patients with multivessel disease, S values corresponding to remote regions were significantly lower (p < 0.01) compared with control subjects. Thus, the parameters obtained from mitral annular velocities with pulsed TDI in patients with previous myocardial infarction reflect left ventricular asynergy corresponding to the infarct regions and reversible regional dysfunction after exercise.

Entities:  

Mesh:

Year:  2000        PMID: 10997350     DOI: 10.1016/s0002-9149(00)00988-7

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  5 in total

1.  Usefulness of mitral annular systolic velocity in the detection of left ventricular systolic dysfunction: comparison with three dimensional echocardiographic data.

Authors:  Yun Seon Park; Jae-Hyeong Park; Kye Taek Ahn; Won Il Jang; Hyung Seo Park; Jun Hyung Kim; Jae-Hwan Lee; Si Wan Choi; Jin-Ok Jeong; In-Whan Seong
Journal:  J Cardiovasc Ultrasound       Date:  2010-03-31

Review 2.  Clinical implications of the echocardiographic assessment of left ventricular long axis function.

Authors:  Konstantinos A Triantafyllou; Elias Karabinos; Heleni Kalkandi; Athanasios I Kranidis; Dimitrios Babalis
Journal:  Clin Res Cardiol       Date:  2009-07-14       Impact factor: 5.460

3.  Use of tissue Doppler echocardiography in early detection of left ventricular systolic dysfunction in patients with mitral regurgitation.

Authors:  Cem Nazli; Ozan Kinay; Oktay Ergene; Turan Yavuz; Omer Gedikli; Yesim Hoscan; Mehmet Ozaydin; Ahmet Altinbas; Abdullah Dogan; Halil Kahraman; Gurkan Acar
Journal:  Int J Cardiovasc Imaging       Date:  2003-06       Impact factor: 2.357

4.  Impacts of mitral E/e' on myocardial contractile motion and synchronicity in heart failure patients with reduced ejection fraction: An exercise-echocardiography study.

Authors:  Yi-Chih Wang; Chih-Chieh Yu; Fu-Chun Chiu; Chia-Ti Tsai; Ling-Ping Lai; Juey-Jen Hwang; Jiunn-Lee Lin
Journal:  Clin Cardiol       Date:  2013-05-13       Impact factor: 2.882

5.  Evaluation of myocardial function in pediatric patients with transposition of great arteries after arterial switch operation.

Authors:  Taliha Öner; Rahmi Özdemir; Barış Güven; Murat Muhtar Yılmazer; Önder Doksöz; Timur Meşe; Vedide Tavlı
Journal:  Anatol J Cardiol       Date:  2016-01       Impact factor: 1.596

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.